FindTrial
Sign In

Hemodynamic study of high altitude heart disease

Hemodynamic study of high altitude heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026613
Enrollment
Unknown
Registered
2019-10-16
Start date
2019-10-25
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High altitude heart disease

Interventions

high altitude heart disease group:N/A
left heart failure group:N/A

Sponsors

People's Hospital of Tibet Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Conformity with the diagnostic criteria of high altitude heart disease and left heart failure; 2. Subjects and their family members have informed consent to the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. No Picco hemodynamic monitor for any reason; 2. Complicated with diabetes mellitus, hyperthyroidism, cerebrovascular diseases, severe hematological diseases, tumors, severe pulmonary diseases, congenital heart malformation, obvious infection, severe liver and kidney dysfunction, etc.; 3. 3-month history of major surgery.

Design outcomes

Primary

MeasureTime frame
GEF;CFI;dPmx;CPI;ITBV;GEDV;SVV;PVV;CO;SV;SVR;AP;CVP;EVLW;PVPI;ScvO2;DO2;VO2;BP;—

Secondary

MeasureTime frame
Blood RT;Liver function;Renal function;Oxygen saturation;Chest X-ray;ECG;UCG;BNP;Routine urine;Stool routine + occult blood;—

Countries

China

Contacts

Public ContactLuobu Gesang, Qiong Wang

People's Hospital of Tibet Autonomous Region

gesang5354@sina.com+86 13549010066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026